| Literature DB >> 31079137 |
Rui Xu1, Zhonghan Wang2, Zhenxiao Ren1, Tingjian Ma1, Zhe Jia1, Shuyan Fang1, Hui Jin3.
Abstract
BACKGROUND There are many shortcomings in traditional prefabricated rehabilitation insoles for symptomatic flatfoot patients. This study investigated the effects of customized 3-dimensional (3D) printed insoles on pressure and comfort of the plantar foot in symptomatic flatfoot patients. MATERIAL AND METHODS Eighty patients with bilateral flatfoot participated in this study. At week 0, patients were randomly assigned into 1 of 2 groups. In the control group, the patients wore standardize shoes with prefabricated insoles; and in the experimental group the patients wore standardize shoes and customized insoles. The Footscan® system recorded peak pressure, peak force, and peak contact area in 10 areas of the sole at weeks 0 and at week 8. Patients used visual analogue scale scores at week 0 and at week 8 to assess overall comfort of insoles. RESULTS At week 0, compared with the control group, the peak pressure in the metatarsal was significantly lower in the experimental group (P<0.05) while the peak pressure in the mid-foot was significantly higher than the control group (P<0.05). At week 8, in the experimental group, the peak pressures in the mid-foot were significantly higher than the control group (P<0.05). The comfort scores (measured by pain scale) reported by the experimental group were significantly lower than those reported by the control group (P<0.05). CONCLUSIONS Customized 3D printed insoles reduced the pressure on the metatarsals by distributed it over the mid-foot area, thus reduced the damage from symptomatic flatfoot. Customized 3D printed insoles were more effective than prefabricated insoles and offered better comfort for patients with symptomatic flatfoot.Entities:
Mesh:
Year: 2019 PMID: 31079137 PMCID: PMC6528551 DOI: 10.12659/MSM.916975
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Demographic characteristics of the participants (N=80).
| Characteristics | Experimental group | Control group | ||
|---|---|---|---|---|
| Mean (SD) | Range | Mean (SD) | Range | |
| Age (years) | 38.61 (7.41) | 26–55 | 41.52 (4.28) | 29–60 |
| Sex | 20 males, 20 females | 20 males, 20 females | ||
| Weight (kg) | 63.37 (12.52) | 48–88 | 67.18 (10.72) | 50–86 |
| BMI (kg/m2) | 26.56 (12.42) | 15.9–29.7 | 25.71 (10.41) | 17.4–28.3 |
| FPI | +7m (2.12) | +6–+8 | +7 (2.61) | +6–+9 |
| Wearing time (hours/day) | 6.7 (2.31) | 4.3–9.7 | 7.1 (3.31) | 5.31–10.72 |
| VA | ||||
| 0 week | 7.91 (3.11) | 8.12 (1.21) | 0.87 | |
| 8th week | 2.42 (0.13) | 5.92 (1.19) | 0.03 | |
| P values | 0.01 | 0.25 | ||
SD – standard deviation; BMI – body mass index; FPI – foot posture index; VAS – Visual Analogue Scale.
Figure 1(A) Customized 3D printed insole; (B) prefabricated insole.
Figure 2The Footscan® system can record the peak value of pressure, force, and contact area in full cycle of gait.
Figure 3The Footscan® system divides the sole into 10 areas: the big toe (T1), toes 2–5 (T2–T5), the 1st to 5th metatarsal (M1, M2, M3, M4, and M5), midfoot (MF), medial heel (H1, MH), and lateral heel (H2, LH).
Figure 4Flow chart of study participants, following the Consolidated Standards of Reporting Trials guidelines.
Comparison of the experimental group and control group at week 0.
| Areas | Peak pressure (kPa) | Peak force (N) | Peak contact area (cm2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CI | PI | p | CI | PI | p | CI | PI | p | |
| T1 | 101.21±50.61 | 140.80±191.50 | 0.42 | 137.91±100.21 | 109.71±53.21 | 0.64 | 12.30±100.20 | 14.10±6.70 | 0.40 |
| T2–5 | 34.31±18.12 | 67.40±80.10 | 0.27 | 34.31±27.91 | 41.21±42.21 | 0.49 | 8.20±4.30 | 6.80±5.70 | 0.61 |
| M1 | 71.00±68.71 | 135.51±68.22 | 0.08 | 43.71±33.11 | 120.71±82.00 | 0.01 | 7.20±3.40 | 7.20±3.80 | 0.60 |
| M2 | 192.61±90.91 | 280.61±251.41 | 0.31 | 166.71±87.8 | 117.12±82.13 | 0.78 | 7.90±2.80 | 7.00±3.30 | 0.82 |
| M3 | 202.91±69.11 | 400.00±263.41 | 0.04 | 149.61±85.11 | 234.41±207.14 | 0.23 | 10.40±12.90 | 6.20±2.50 | 0.66 |
| M4 | 197.11±75.31 | 318.43±172.63 | 0.18 | 150.21±79.61 | 188.71±126.11 | 0.46 | 7.00±1.90 | 6.40±2.80 | 0.97 |
| M5 | 142.51±69.00 | 140.73±78.73 | 0.93 | 154.71±95.82 | 136.17±97.61 | 0.78 | 10.60±2.80 | 9.60±4.20 | 0.33 |
| MF | 113.71±22.41 | 45.33±53.23 | 0.04 | 394.12±153.31 | 220.11±321.11 | 0.46 | 33.10±10.60 | 35.40±16.90 | 0.66 |
| MH | 195.11±70.21 | 166.63±60.51 | 0.46 | 285.61±183.21 | 236.21±157.00 | 0.79 | 12.9±4.8 | 12.8±6.2 | 0.66 |
| LH | 178.71±61.92 | 167.63±88.71 | 0.87 | 221.10±130.80 | 201.11±148.90 | 0.96 | 11.2±4.1 | 11.4±5.6 | 0.56 |
p<0.05, indicating a significant difference; values are expressed as means ±standard deviations.
CI – customized insole; PI – prefabricated insole; T1 – hallux; T2–5 – toes 2–5; M1 – 1st metatarsal; M2 – 2nd metatarsal; M3 – 3rd metatarsal; M4 – 4th metatarsal; M5 – 5th metatarsal; MF – midfoot; MH – medial heel; LH – lateral heel.
Comparison of the experimental and control groups at week 8.
| Areas | Peak pressure (kPa) | Peak force (N) | Peak contact area (cm2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CI | PI | p | CI | PI | p | CI | PI | p | |
| T1 | 126.21±46.61 | 105.60±109.70 | 0.89 | 153.20±80.90 | 109.71±44.91 | 0.21 | 11.10±2.50 | 14.61±6.11 | 0.36 |
| T2–5 | 56.31±27.51 | 42.20±48.50 | 0.85 | 50.70±41.90 | 34.71±34.51 | 0.84 | 8.80±5.30 | 11.51±6.21 | 0.36 |
| M1 | 118.50±152.60 | 164.00±57.31 | 0.69 | 97.41±51.81 | 145.30±100.40 | 0.25 | 7.90±3.50 | 12.41±5.21 | 0.17 |
| M2 | 176.7±56.71 | 201.60±199.30 | 0.61 | 158.20±96.70 | 177.11±64.11 | 0.62 | 7.90±3.30 | 11.61±4.11 | 0.14 |
| M3 | 239.20±100.10 | 286.41±250.61 | 0.42 | 138.00±93.60 | 225.31±95.21 | 0.13 | 6.20±2.30 | 10.11±3.41 | 0.04 |
| M4 | 144.20±60.00 | 169.51±42.61 | 0.75 | 104.30±61.20 | 143.30±79.60 | 0.61 | 6.70±2.70 | 10.22±3.31 | 0.04 |
| M5 | 113.41±56.51 | 71.31±33.71 | 0.52 | 123.50±71.40 | 86.90±58.40 | 0.68 | 9.60±3.90 | 12.31±4.61 | 0.48 |
| MF | 112.21±11.81 | 44.13±31.11 | 0.04 | 422.60±147.80 | 119.80±104.70 | 0.01 | 36.30±12.20 | 30.21±11.71 | 0.23 |
| MH | 206.71±57.21 | 161.81±78.22 | 0.87 | 293.50±149.90 | 219.2±100.50 | 0.79 | 12.90±4.80 | 14.90±5.50 | 0.47 |
| LH | 199.31±58.61 | 177.31±104.21 | 0.74 | 240.30±139.10 | 209.40±112.20 | 0.81 | 11.10±4.20 | 13.30±4.90 | 0.38 |
p<0.05, indicating a significant difference; values are expressed as means ±standard deviations.
CI – customized insole; PI – prefabricated insole; T1 – hallux; T2–5 – toes 2–5; M1 – 1st metatarsal; M2 – 2nd metatarsal; M3 – 3rd metatarsal; M4 – 4th metatarsal; M5 – 5th metatarsal; MF – midfoot; MH – medial heel; LH – lateral heel.
Comparison of study parameters in the control group at week 0 and week 8.
| Areas | Peak pressure (kPa) | Peak force (N) | Peak contact area (cm2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 0PI | 8PI | p | 0PI | 8PI | p | 0PI | 8PI | p | |
| T1 | 140.81±191.52 | 105.60±109.70 | 0.45 | 109.71±53.12 | 109.72±44.91 | 0.72 | 14.10±6.70 | 14.61±6.11 | 0.55 |
| T2–5 | 67.41±80.11 | 42.20±48.50 | 0.85 | 41.21±42.21 | 34.71±34.51 | 0.69 | 6.80±5.70 | 11.51±6.22 | 0.16 |
| M1 | 135.51±68.22 | 164.00±57.31 | 0.32 | 120.71±82.00 | 145.30±100.40 | 0.02 | 7.20±3.40 | 12.41±5.22 | 0.17 |
| M2 | 280.60±251.40 | 201.60±199.30 | 0.82 | 117.20±82.30 | 177.11±64.11 | 0.34 | 7.00±3.31 | 11.61±4.11 | 0.23 |
| M3 | 400.00±263.40 | 286.41±250.61 | 0.38 | 234.41±207.42 | 225.31±95.21 | 0.61 | 6.21±2.51 | 10.11±3.41 | 0.21 |
| M4 | 318.40±172.60 | 169.51±42.61 | 0.04 | 188.71±126.11 | 143.31±79.61 | 0.17 | 6.41±2.81 | 10.22±3.31 | 0.25 |
| M5 | 140.70±78.70 | 71.31±33.71 | 0.03 | 136.71±97.61 | 86.90±58.40 | 0.03 | 9.60±4.20 | 12.31±4.62 | 0.796 |
| MF | 45.30±53.20 | 44.11±31.12 | 0.97 | 220.11±321.11 | 119.80±104.70 | 0.21 | 30.21±11.72 | 35.41±16.90 | 0.03 |
| MH | 166.60±60.50 | 161.81±78.22 | 0.59 | 236.21±157.00 | 219.20±100.50 | 0.53 | 12.81±6.21 | 14.91±5.53 | 0.84 |
| LH | 167.60±88.70 | 177.31±104.21 | 0.31 | 201.10±148.90 | 209.40±112.20 | 0.91 | 11.41±5.61 | 13.31±4.91 | 0.92 |
p<0.05, indicating a significant difference; values are expressed as means ±standard deviations.
0PI – 0 week prefabricated insole; 8PI – 8th week prefabricated insole; T1 – hallux; T2–5 – toes 2–5; M1 – 1st metatarsal; M2 – 2nd metatarsal; M3 – 3rd metatarsal; M4 – 4th metatarsal; M5 – 5th metatarsal; MF – midfoot; MH – medial heel; LH – lateral heel.
Comparison of the study parameters in the experimental group at week 0 and week 8.
| Areas | Peak pressure (kPa) | Peak force (N) | Peak contact area (cm2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 0PI | 8PI | p | 0PI | 8PI | p | 0PI | 8PI | p | |
| T1 | 101.21±50.61 | 126.21±46.61 | 0.01 | 137.91±100.21 | 153.21±80.91 | 0.67 | 12.31±100.21 | 11.11±2.52 | 0.19 |
| T2–5 | 34.31±18.11 | 56.31±27.52 | 0.03 | 34.32±27.92 | 50.71±41.91 | 0.04 | 8.22±4.32 | 8.81±5.32 | 0.62 |
| M1 | 71.00±68.71 | 118.50±152.60 | 0.94 | 43.71±33.11 | 145.31±100.41 | 0.18 | 7.20±3.40 | 7.90±3.50 | 0.38 |
| M2 | 192.63±90.93 | 176.72±56.71 | 0.46 | 166.71±87.81 | 158.23±96.71 | 0.56 | 7.91±2.82 | 7.92±3.32 | 0.81 |
| M3 | 202.91±69.11 | 239.20±100.10 | 0.68 | 149.62±85.12 | 138.00±93.60 | 0.46 | 10.42±12.91 | 6.20±2.30 | 0.30 |
| M4 | 197.12±75.31 | 144.20±60.00 | 0.47 | 150.23±79.62 | 104.30±61.20 | 0.02 | 7.01±1.92 | 6.70±2.70 | 0.42 |
| M5 | 142.52±69.00 | 113.42±56.52 | 0.17 | 154.71±95.83 | 123.52±71.41 | 0.21 | 10.61±2.81 | 9.61±3.92 | 0.33 |
| MF | 113.71±22.41 | 112.21±11.81 | 0.82 | 394.11±153.31 | 422.62±147.82 | 0.35 | 33.12±10.61 | 36.32±12.22 | 0.03 |
| MH | 195.11±70.23 | 206.72±57.22 | 0.37 | 285.62±183.22 | 293.51±149.92 | 0.73 | 12.91±4.82 | 12.92±4.82 | 0.93 |
| LH | 178.72±61.91 | 199.31±58.61 | 0.07 | 221.00±130.82 | 240.31±139.13 | 0.3 | 11.21±4.11 | 11.11±4.22 | 0.81 |
p<0.05, indicating a significant difference; values are expressed as means ±standard deviations.
0PI – 0 week prefabricated insole; 8PI – 8th week prefabricated insole; T1 – hallux; T2–5 – toes 2–5; M1 – 1st metatarsal; M2 – 2nd metatarsal; M3 – 3rd metatarsal; M4 – 4th metatarsal; M5 – 5th metatarsal; MF – midfoot; MH – medial heel; LH – lateral heel.